Rafferty Joseph 4
4 · BioSig Technologies, Inc. · Filed Mar 8, 2018
Insider Transaction Report
Form 4
Rafferty Joseph
Chief CommercializationOfficer
Transactions
- Award
Stock Option (Right to Buy)
2017-11-24+420,000→ 420,000 totalExercise: $1.45Exp: 2027-11-24→ Common Stock (420,000 underlying) - Purchase
Common Stock
2018-03-05$1.40/sh+7,000$9,800→ 7,000 total
Footnotes (1)
- [F1]120,000 of the optioned shares vested on November 24, 2017. The remaining optioned shares shall vest as follows: (i) 50,000 on November 24, 2019; (ii) 100,000 shares on the date that the first entity to have a PURE EP System installed converts to a paying customer of the company; (iii) 50,000 on the date that the company first files financial statements with the U.S. Securities and Exchange Commission on Form 10-K or Form 10-Q that report revenues, calculated in accordance with generally accepted accounting principles; and (iv) 100,000 on the date that the company first files financial statements with the U.S. Securities and Exchange Commission on Form 10-K that report annual revenues of at least $10,000,000, calculated in accordance with generally accepted accounting principles.